Skip to main content
Clinical Trials/NCT05314218
NCT05314218
Completed
Not Applicable

EPICADIA - Electrophysiologic Performance Investigation for CArdiac DIAgnosis

Alcis2 sites in 1 country168 target enrollmentMay 23, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiac Arrhythmia
Sponsor
Alcis
Enrollment
168
Locations
2
Primary Endpoint
Signal quality
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The objective of this multicentre study is to collect operative data on the related clinical functional outcomes and complications and of market approved Alcis electrophysiology catheters to demonstrate safety and performance of these devices in a real-world setting.

Detailed Description

Outcome data collected from this study will provide the basis for Post-Market Surveillance (PMS) reporting, Clinical Study Report (CSR), Clinical Evaluation Report (CER) on Alcis devices and support peer-reviewed publications on products performance and safety.

Registry
clinicaltrials.gov
Start Date
May 23, 2022
End Date
May 26, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Alcis
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • To be included, patients must be:
  • 18 to 90 years old
  • Patient who have to undergo diagnostic procedure or ablation procedure (Cardiac arrythmias)
  • Informed and willing to sign an informed consent for approved by EC
  • Affiliation to the social security or foreign regime recognized in France

Exclusion Criteria

  • A patient will not be eligible to participate in the study if any of the following conditions are present:
  • Not able to comply with the study procedures based on the judgment of the assessor (e.g. cannot comprehend study questions, inability to keep scheduled assessment times).
  • Any medical condition that could impact the study at investigator's discretion (e.g. allergy...).
  • Pregnant women
  • Adult subject to legal protection measure

Outcomes

Primary Outcomes

Signal quality

Time Frame: Through study completion, an average of 4 hours

Good signal amplitude and signal stability throughout the procedure without artefact

Secondary Outcomes

  • Imaging(Through study completion, an average of 4 hours)
  • Micro-stimulation(Through study completion, an average of 4 hours)
  • Bending(Through study completion, an average of 4 hours)
  • Diagnosis(Through study completion, an average of 4 hours)
  • Manoeuvrability(Through study completion, an average of 4 hours)

Study Sites (2)

Loading locations...

Similar Trials